| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 05/24/2000 | EP1002106A1 Production and use of recombinant protein multimers with altered biological activity |
| 05/24/2000 | EP1002105A1 Fusion proteins comprising coiled-coil structures derived of bovine if1 atpase inhibitor protein |
| 05/24/2000 | EP1002093A1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 05/24/2000 | EP1002075A1 Adipocyte-specific protein homologs |
| 05/24/2000 | EP1002073A2 Cell activation process and reagents therefor |
| 05/24/2000 | EP1001815A1 Vectors derived from antibodies for transferring substances into cells |
| 05/24/2000 | CN1254379A Methods of production of amidated peptide through use of fusion protein |
| 05/24/2000 | CN1052732C Process for preparing anti-cancer synergist taking IL-2 as main component made from pig blood, sheep blood, pig spleen and sheep spleen |
| 05/23/2000 | US6066503 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 05/23/2000 | US6066498 Compositions for the treatment and diagnosis of immune disorders |
| 05/23/2000 | US6066324 Carboxyl terminal of papilloma virus L1 region is not required for formation of virus-like particles |
| 05/23/2000 | US6066322 Administering antibody to treat asthma; treating helper t-cell mediated conditions |
| 05/18/2000 | WO2000028039A2 Identification of senv genotypes |
| 05/18/2000 | WO2000028020A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 05/18/2000 | WO2000028011A2 Fk506-based regulation of biological events |
| 05/18/2000 | WO2000028004A1 Virus vectors and methods of making and administering the same |
| 05/18/2000 | WO2000027880A2 Rantes-derived peptides with anti-hiv activity |
| 05/18/2000 | WO2000027432A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 05/18/2000 | WO2000009730A3 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 05/18/2000 | WO1999024470A8 Mammalian milk growth factor |
| 05/18/2000 | CA2350183A1 Use of an enterobacterium protein ompa for specific targeting towards antigen-presenting cells |
| 05/18/2000 | CA2350086A1 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 05/18/2000 | CA2348382A1 Chimeric parvovirus vectors and methods of making and administering the same |
| 05/18/2000 | CA2348308A1 Rantes-derived peptides with anti-hiv activity |
| 05/18/2000 | CA2346962A1 Fk506-based regulation of biological events |
| 05/17/2000 | EP1001030A1 Recombinant CELO virus and CELO virus DNA |
| 05/17/2000 | EP1001025A2 Outer membrane proteins from actinobacillus pleuropneumoniae |
| 05/17/2000 | EP1000357A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application |
| 05/17/2000 | EP1000166A2 Inhibitors of cell-cycle progression and uses related thereto |
| 05/17/2000 | EP1000161A1 Anticoagulant fusion protein anchored to cell membrane |
| 05/17/2000 | EP1000149A2 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 05/17/2000 | EP1000147A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 05/17/2000 | EP0999849A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
| 05/17/2000 | EP0934425A4 Renilla luciferase and green fluorescent protein fusion genes |
| 05/17/2000 | CN1253567A Cell surface molecule mediating cell adhesion and signal transmission |
| 05/11/2000 | WO2000026380A1 Rotavirus subunit vaccine |
| 05/11/2000 | WO2000026376A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
| 05/11/2000 | WO2000026251A2 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX |
| 05/11/2000 | WO2000026241A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 05/11/2000 | WO2000026239A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026237A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000025831A1 A new composition and method for increasing production yield of agriculturally useful species |
| 05/11/2000 | WO2000025725A2 Functional antagonists of hedgehog activity |
| 05/11/2000 | WO2000008158A3 Molecules designated ldcam |
| 05/11/2000 | WO2000008043A3 Prevention and treatment of viral disease |
| 05/11/2000 | CA2349504A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 05/11/2000 | CA2348960A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2348958A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2348777A1 Rotavirus subunit vaccine |
| 05/11/2000 | CA2348733A1 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 05/10/2000 | EP0998573A2 Fusion proteins with an immunoglobulin hinge region linker |
| 05/10/2000 | EP0998496A1 Isolated dendritic cell membrane protein genes |
| 05/10/2000 | EP0998307A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 05/10/2000 | EP0998305A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 05/10/2000 | CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA |
| 05/10/2000 | CN1252716A Inhibitor of leaderless protein export |
| 05/10/2000 | CN1052239C Method for preparation of NTPS |
| 05/09/2000 | US6060276 Nucleotide sequences for proteins involved in signal transduction; for assays to detect/measure ligands; diagnosis and therapy of endocrine disorders; gene therapy; antisense agents; transgenic animals |
| 05/09/2000 | CA2057860C Immunoactive peptides and antibodies and their use in anti-allergy treatment |
| 05/04/2000 | WO2000024902A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | WO2000024897A1 Cell surface molecule-induced macrophage activation |
| 05/04/2000 | WO2000024884A2 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
| 05/04/2000 | WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents |
| 05/04/2000 | WO2000024770A2 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
| 05/04/2000 | WO1999067283A8 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 05/04/2000 | CA2348839A1 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
| 05/04/2000 | CA2348747A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | CA2346996A1 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
| 05/03/2000 | EP0997477A2 MHC complexes and uses thereof |
| 05/03/2000 | EP0996716A1 Zggbp1,novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
| 05/03/2000 | EP0996457A1 Fsh-releasing peptides |
| 05/03/2000 | EP0812204A4 Codominance-mediated toxins |
| 05/03/2000 | EP0560947B1 Trivalent monospecific antigen binding proteins |
| 05/03/2000 | EP0514481B1 Merosin, nucleic acids encoding, fragments and uses thereof |
| 05/03/2000 | EP0383803B1 Oligonucleotide-polyamide conjugates |
| 05/02/2000 | US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition |
| 05/02/2000 | US6057426 Nucleotide and amino acid sequences of polypeptide capable of inducing leukocyte migration and/or activating leukocytes in a dose-dependent manner; diagnosis/screening/therapy; for increasing cell layer permeability for drug circulation |
| 05/02/2000 | US6057133 Fusion protein associated with cell growth and regulation; for the activation of bone marrow propagation; for treatment of cancer, asthma and inflammation |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/02/2000 | CA2105057C Dna sequences which code for virulence characteristics of streptococcus suis and part thereof polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 05/02/2000 | CA2104014C Structural gene of pneumococcal protein |
| 05/02/2000 | CA1340982C Protamine-reactive igm antibodies |
| 04/27/2000 | WO2000023955A1 Virus-like particles for the induction of autoantibodies |
| 04/27/2000 | WO2000023602A2 Regulated expression using conditional er retention domains |
| 04/27/2000 | WO2000023600A1 Materials and methods involving conditional aggregation domains |
| 04/27/2000 | WO2000023593A2 Molecular pathogenicide mediated plant disease resistance |
| 04/27/2000 | WO2000023580A1 A method of affinity separation and ligands for use therein |
| 04/27/2000 | WO2000023570A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023473A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | WO2000023472A2 Interferon-beta fusion proteins and uses |
| 04/27/2000 | WO2000023464A2 Zinc finger binding domains for gnn |
| 04/27/2000 | WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses |
| 04/27/2000 | WO2000023113A1 Peptide-based carrier devices for stellate cells |
| 04/27/2000 | WO2000023087A1 Polyspecific binding molecules and uses thereof |
| 04/27/2000 | WO2000006742A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/27/2000 | WO2000001827A3 Polyketides, their preparation, and materials for use therein |